Lantheus (LNTH) Grants AHN Exclusive Rights for Use of Microbubbles in Combination with Ultrasound Assisted Gene Therapy for Development of Proposed Treatment for Xerostomia

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. DFTX
7. GOOGL
8. MU
9. HOOD
10. IBM

Go back to Lantheus (LNTH) Grants AHN Exclusive Rights for Use of Microbubbles in Combination with Ultrasound Assisted Gene Therapy for Development of Proposed Treatment for Xerostomia

Lantheus Holdings (LNTH) Tops Q1 EPS by 6c, Revenues Beat; Raises FY21 EPS/Revenues Guidance

May 4, 2021 7:20 AM EDT

Lantheus Holdings (NASDAQ: LNTH) reported Q1 EPS of $0.05, $0.06 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $92.51 million versus the consensus estimate of $87.24 million.

Worldwide revenue of $92.5 million for the first quarter 2021, representing an increase of 2.0% from the prior year periodNet income of $9.0 million for the first quarter 2021, compared to net income of $3.3 million in the prior year... More